Congenital Oropouche in Humans: Clinical Characterization of a Possible New Teratogenic Syndrome
- PMID: 40143324
- PMCID: PMC11945744
- DOI: 10.3390/v17030397
Congenital Oropouche in Humans: Clinical Characterization of a Possible New Teratogenic Syndrome
Abstract
Oropouche fever is caused by the Oropouche virus (OROV; Bunyaviridae, Orthobunyavirus), one of the most frequent arboviruses that infect humans in the Brazilian Amazon. This year, an OROV outbreak was identified in Brazil, and its vertical transmission was reported, which was associated with fetal death and microcephaly. We describe the clinical manifestations identified in three cases of congenital OROV infection with confirmed serology (OROV-IgM) in the mother-newborn binomial. One of the newborns died, and post-mortem molecular analysis using real-time RT-qPCR identified the OROV genome in several tissues. All three newborns were born in the Amazon region in Brazil, and the mothers reported fever, rash, headache, myalgia, and/or retro-orbital pain during pregnancy. The newborns presented with severe microcephaly secondary to brain damage and arthrogryposis, suggestive of an embryo/fetal disruptive process at birth. Brain and spinal images identified overlapping sutures, cerebral atrophy, brain cysts, thinning of the spinal cord, corpus callosum, and posterior fossa abnormalities. Fundoscopic findings included macular chorioretinal scars, focal pigment mottling, and vascular attenuation. The clinical presentation of vertical OROV infection resembled congenital Zika syndrome to some extent but presents some distinctive features on brain imaging and in several aspects of its neurological presentation. A recognizable syndrome with severe brain damage, neurological alterations, arthrogryposis, and fundoscopic abnormalities can be associated with in utero OROV infection.
Keywords: Oropouche fever; congenital anomalies; microcephaly; vertical transmission.
Conflict of interest statement
The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures
References
-
- Azevedo E.d.A.N., da Silva A.F., da Silva V.G., Machado L.C., de Lima G.B., Ishigami B.I.M., Silva K.M.P.e., Costa M.M.d.O.M.d., Falcão D.A., Vasconcelos A.P., et al. Genomic and phenotypic characterization of the Oropouche virus strain implicated in the 2022–24 large-scale outbreak in Brazil. J. Med. Virol. 2024;96:e70012. doi: 10.1002/jmv.70012. - DOI - PubMed
-
- Chiang J.O., Justino M.C.A., Matos H.J., Cabeça H.L.S., Silva S.P., Henriques D.F., Silva E.V.P., Andrade G.S.S., Vasconcelos P.F., Martins L.C., et al. Neurological disease caused by Oropouche virus in northern Brazil: Should it be included in the scope of clinical neurological diseases? J. Neurovirology. 2021;27:626–630. doi: 10.1007/s13365-021-00987-9. - DOI - PMC - PubMed
-
- Brazil, Secretaria de Vigilância em Saúde e Ambiente. Recomendação para Intensificação da Vigilância de Transmissão Vertical do Vírus Oropouche. Nota Técnica Nº 15/2024-SVSA/MS. Brasil. Ministério da Saúde. [(accessed on 5 August 2024)];2024 Available online: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/notas-te....
-
- Pan American Health Organization. World Health Organization . Epidemiological Update Oropouche in the Americas Region—6 September 2024. OPS/OMS; Washington, DC, USA: 2024. [(accessed on 9 September 2024)]. Available online: https://www.paho.org/en/documents/epidemiological-update-oropouche-ameri....
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
